{"id":"sulfaethidole","rwe":[],"tags":[{"label":"sulfaethidole","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"RAC-alpha serine/threonine-protein kinase","category":"target"},{"label":"AKT1","category":"gene"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"ethazole","offLabel":[],"synonyms":["sulfaethidole","sulfaethylthiadiazole","sulfaethidol","sulfaethidiole","ethazole"],"timeline":[],"aiSummary":"Ethazole is a small molecule. It is also known by the synonyms SULFAETHIDOLE, SULFAETIDOL, and SUL-SPANSION.","approvals":[],"brandName":"Ethazole","ecosystem":[],"mechanism":{"target":"RAC-alpha serine/threonine-protein kinase","targets":[{"gene":"AKT1","source":"DrugCentral","target":"RAC-alpha serine/threonine-protein kinase","protein":"RAC-alpha serine/threonine-protein kinase"}],"modality":"Small Molecule","drugClass":"sulfaethidole","explanation":"Think of cell signaling like a messenger system. RAC-alpha serine/threonine-protein kinase is a key messenger that helps cells respond to their environment. By blocking this messenger, Ethazole can potentially disrupt abnormal cell growth and behavior.","oneSentence":"Ethazole works by inhibiting the RAC-alpha serine/threonine-protein kinase enzyme, which plays a crucial role in cell signaling pathways.","technicalDetail":"Ethazole specifically binds to the ATP-binding site of RAC-alpha serine/threonine-protein kinase, thereby inhibiting its kinase activity and disrupting downstream signaling pathways."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/2504","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=SULFAETHIDOLE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T15:44:41.127973","biosimilars":[],"competitors":[{"drugName":"midostaurin","drugSlug":"midostaurin","fdaApproval":"2017-04-28","patentExpiry":"Oct 9, 2028","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"miltefosine","drugSlug":"miltefosine","fdaApproval":"2014-03-19","patentStatus":"Unknown","relationship":"same-target"},{"drugName":"niclosamide","drugSlug":"niclosamide","fdaApproval":"","patentStatus":"Unknown","relationship":"same-target"}],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"genericName":"sulfaethidole","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"midostaurin","brandName":"midostaurin","genericName":"midostaurin","approvalYear":"2017","relationship":"same-target"},{"drugId":"miltefosine","brandName":"miltefosine","genericName":"miltefosine","approvalYear":"2014","relationship":"same-target"},{"drugId":"niclosamide","brandName":"niclosamide","genericName":"niclosamide","approvalYear":"","relationship":"same-target"}],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"crossReferences":{"NDDF":"002826","UNII":"R77Q4O5ZMD","CHEBI":"CHEBI:107668","INN_ID":"749","RXNORM":"37324","UMLSCUI":"C0075508","ChEMBL_ID":"CHEMBL1355299","KEGG_DRUG":"D02449","PUBCHEM_CID":"7181","SNOMEDCT_US":"4480008","MESH_SUPPLEMENTAL_RECORD_UI":"C100299"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}